Introduction
Analysis was stratified by the type of troponin measured (I and T) and age group 135 (<65, 65-74, 75-84 and ≥85 years) . For each troponin type, we re-categorised six categories 136 (troponin specific) based on pre-specified cut off points. The cut off points for troponin I The explanatory variables in the Cox models were troponin I or T levels, age group,
145
sex, BMI, current smokers, family history of heart disease, STEMI or non-STEMI, co-146 morbidities (hypertension, diabetes, MI, angina, stroke, heart failure, chronic renal failure,
147
peripheral vascular disease), previous PCI, previous CABG, serum cholesterol, serum 148 glucose, troponin group, medications prior to admission (aspirin, ACEi, statin, 149 clopidogrel), speciality of consultant in charge at the time of admission and admission ward.
150
All of these variables were independently associated with time to death in the full models.
151
We adjusted for medications that patients had been taking on admission because there were The characteristics of the study sample by peak troponin specific group stratified by 172 different age groups are shown in Table 1 . There were a decreasing proportion of men,
173
current smokers and participants with a positive family history of heart disease with older age 174 groups. In all age groups, the most common known co-morbidities were hypertension and 175 hyperlipidaemia, the former more common with older age, the latter less common. (see Supplementary Figure 2 ).
194
The hazard ratios for mortality in older age groups compared to the youngest age group, stratified by troponins levels, are shown in hazard ratio of 1.00) showed adjusted HRs 11.70 and 9.24 respectively for troponin I and T).
202
The age-troponin interaction term was statistically significant for both troponin I and troponin
203
T models (P<0.0001).
205
The hazards ratios of mortality associated with troponin levels stratified by age are (CI) 1.80-3.24); age ≥85 HR 2.01 (1.62-2.52)). A similar attenuation was observed for troponin T up to troponin levels of 0.1; however at levels higher than 0.1, the relative potency 212 of troponin to predict an adverse outcome did not attenuate with increased age.
214
Secondary sensitivity analyses by additionally adjusting for discharge medications and
215
reperfusion strategies in the model did not alter the results (data not shown).
217
The Cox proportional hazards assumptions were met for all outcome analyses.
Discussion
Our results showed that in any age group, higher troponin levels were associated with 221 increasing risk of mortality. We found very high mortality rates in older patients even at the In conclusion, we have shown that the prognostic significance of troponin in ACS
326
attenuates with increased age and that older age is associated with a worse prognosis 327 compared to younger counterparts given the same level of troponin rise, even at very low 328 levels of troponin. Therefore, the age of the patient should be taken into consideration when Competing interests:
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